ConductScience.org, home

Gene · 5928

Papers2,308

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

81 to 100 of 2,308

Download this page as JSON
TitleJournalYearPMIDFound bySource
Deficient mismatch repair/microsatellite instability-high colorectal cancer: current treatment paradigms, limitations and future perspectives.BMJ Oncol202641710674PubTator, text miningPubMed
Enhancing NK Cell Activity in Colorectal Cancer with an Fc-Optimized Antibody Targeting CD276 (B7-H3).Immunotargets Ther202641710281PubTator, text miningPubMed
NFATc3 Enhances DREAM Complex-Driven Transactivation.bioRxiv202641648269PubTator, text miningPubMed
Digital Biomarkers for Precision Early Detection of Lung Cancer: Integrating AI-Driven Multi-Omics Into Clinical Pathways.Cancer Med202641645653PubTator, text miningPubMed
Mass spectrometry-based human spatial omics: fundamentals, innovations, and applications.J Biomed Sci202641645178PubTator, text miningPubMed
Impact of gross tumor morphology on the clinical outcomes of colon cancer: multicenter retrospective cohort study.Int J Colorectal Dis202641639274PubTator, text miningPubMed
Prognostic and Clinicopathological Evaluation of NOTCH-1 Expression in Endometrial Carcinoma.Appl Immunohistochem Mol Morphol202641634899PubTator, text miningPubMed
Small SMT-Like MSI-High Colon Cancer Masquerading as a Neuroendocrine Tumor.Dig Dis Sci202641622385PubTator, text miningPubMed
Metastatic organotropism in peritoneal metastasis: Paget's hypothesis revisited.Clin Exp Med202641609906PubTator, text miningPubMed
Real-World Survival Outcomes Following Metastasectomy in RAS Wild-Type mCRC: Insights from a Multicentre National Cohort Study.J Clin Med202641598406PubTator, text miningPubMed
Association of TIGIT and CD155 with KRAS, NRAS, BRAF, PIK3CA, and AKT Gene Mutations, MSI Status, and Cytokine Profiles in Colorectal Cancer.Int J Mol Sci202641596586PubTator, text miningPubMed
Clinical predictors of prognosis in patients with advanced non-small cell lung cancer receiving immunotherapy.Medicine (Baltimore)202641578581PubTator, text miningPubMed
Propionate metabolism-related molecular subtypes and prognostic signature in lung adenocarcinoma.Medicine (Baltimore)202641578551PubTator, text miningPubMed
Ferroptosis-related gene signature predicts prognosis and immunotherapy response in hepatocellular carcinoma: A multi-cohort retrospective study.Medicine (Baltimore)202641578512PubTator, text miningPubMed
Native T1-mapping using cardiovascular magnetic resonance detects myocardium at risk during the first week following myocardial infarction in a swine model and in patients - comparison to contrast-enhanced cine steady-state free precession.
BMC Cardiovasc Disord202641572180PubTator, text miningPubMed
Neoadjuvant chemoradiotherapy plus sintilimab in proficient mismatch repair locally advanced rectal cancer with intermediate/high-immunoscore (SILAR): a single-arm phase II trial.Nat Commun202641565630PubTator, text miningPubMed
Pembrolizumab and SBRT for vaginal cuff recurrence of endometrial carcinoma with regression beyond the radiation field.Gynecol Oncol Rep202641561671PubTator, text miningPubMed
Invasive Acantholytic Extramammary Paget's Disease of the Vulva With Mammary Carcinoma-Like Differentiation and MMR Loss: Report of an Unusual Case and Its Clinical Mimics.Gynecol Oncol Rep202641561668PubTator, text miningPubMed
Characterization of ESR1 alterations in patients with breast and gynecologic cancers.Breast Cancer Res202641555446PubTator, text miningPubMed
An evolving pathology: colorectal cancer with metastasis to the axilla; the treatment approach and response.J Surg Case Rep202641552802PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/5928/papers?page=5